These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1172249)

  • 1. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine.
    Nahorski SR
    Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD as an agonist at mesolimbic dopamine receptors.
    Kelly PH; Iversen LL
    Psychopharmacologia; 1975 Dec; 45(2):221-4. PubMed ID: 2943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
    Pycock C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of ethanol intoxication by dopamine agonists and antagonists.
    Bacopoulos NG; Bize I; Levine J; Van Orden LS
    Psychopharmacology (Berl); 1979 Jan; 60(2):195-201. PubMed ID: 106430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M; Forler C; Palfreyman MG
    Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H; Consolo S; Bianchi S; Samanin R; Ghezzi D
    Brain Res; 1975 Feb; 84(2):221-6. PubMed ID: 1111831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice.
    Ritzmann RF; Bhargava HN
    Life Sci; 1980 Dec; 27(22):2075-80. PubMed ID: 6782403
    [No Abstract]   [Full Text] [Related]  

  • 17. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH; Miller RJ; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ; Wilcox RE; Randall PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for the stimulation of rat brain dopamine receptors by ergometrine.
    Woodruff GN; Elkhawad AO; Crossman AR
    J Pharm Pharmacol; 1974 Jun; 26(6):455-6. PubMed ID: 4154992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.